newsfilter
← Latest News
PR Newswire·

IsoPlexis' Expanded Cell Therapy Offerings Demonstrated in Nature Medicine Publications

BRANFORD, Conn., Nov. 18, 2021 /PRNewswire/ -- IsoPlexis Corporation (NASDAQ:ISO), the leader in functional single-cell proteomics, today announced the publication of two high-impact clinical research studies in Nature Medicine. Both papers demonstrate